제2형 당뇨 · GLP-1 / GIP

3개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved3 programs
AntibodyCurated CoreFDANovo NordiskApproved

semaglutide (Ozempic / Wegovy, GLP-1, Wegovy, NN9535)

Type 2 diabetes, chronic weight management, CV risk reduction (T2D) · GLP-1 receptor

#GLP-1receptor#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 410Status Approved
AntibodyCurated CoreFDAEli LillyApproved

tirzepatide (Mounjaro / Zepbound, Mounjaro, Zepbound, LY3298176)

Type 2 diabetes, chronic weight management · GLP-1 / GIP receptor

#GLP-1GIPreceptor#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 269Status Approved
CGTLimited DatastaleThe Affiliated Hospital of Xuzh…Preclinical

GLP-1 receptor agonist (GLP-1 receptor agonist)

Type 2 Diabetes Mellitus; Susceptibility, Genetic · Type 2 Diabetes Mellitus

#Type2DiabetesMellitus#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 31Status Recruiting